Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
415K
-
Shares change
-
+379K
-
Total reported value, excl. options
-
$6.06M
-
Value change
-
+$5.58M
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$14.60
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q3 2025
3 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q3 2025.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 415K shares
of 49.8M outstanding shares and own 0.83% of the company stock.
Largest 4 shareholders include Assenagon Asset Management S.A. (415K shares), GAMMA Investing LLC (562 shares), Farther Finance Advisors, LLC (78 shares), and Voya Investment Management LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.